| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 12 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 12 |
| 2 | TACROLIMUS OINTMENT 0.1% | 12 |
| 3 | ISONIAZID | 7 |
| 4 | MYCOPHENOLATE MOFETIL | 6 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 6 |
| 6 | VALGANCICLOVIR | 6 |
| 7 | VALGANCICLOVIR HYDROCHLORIDE | 6 |
| 8 | VALGANCICLOVIR HYDROCHLORIDE POWDER, | 6 |
| 9 | AMIKACIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPRENORPHINE HCL | 3 | 0.0034 |
| 1 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 2 | UBLITUXIMAB | 2 | 0.0005 |
| 3 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 4 | 0.0005 |
| 4 | ISONIAZID | 7 | 0.0004 |
| 5 | HYPROMELLOSE | 1 | 0.0004 |
| 6 | SITAGLIPTIN PHOSPHATE | 1 | 0.0004 |
| 7 | VALGANCICLOVIR | 6 | 0.0003 |
| 8 | AMIKACIN | 5 | 0.0003 |
| 9 | HYDROXOCOBALAMIN | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimycobacterial [EPC] | 7 | 0.0003 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 3 | Aminoglycoside Antibacterial [EPC] | 5 | 0.0001 |
| 4 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 6 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 5 | 0.0000 |
| 7 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Macrolide Antimicrobial [EPC] | 2 | 0.0000 |
| 9 | Serotonin Reuptake Inhibitor [EPC] | 3 | 0.0000 |